Please login to the form below

Not currently logged in
Email:
Password:

David Epstein joins Flagship Pioneering as executive partner

He most recently served as CEO of Novartis Pharmaceuticals

Flagship Pioneering David EpsteinUS-based Flagship Pioneering has appointed former Novartis Pharmaceuticals chief executive David Epstein as its executive partner.

In this newly-created position, Epstein will begin working with Rubius Therapeutics, a red blood cell-focused exploratory venture within the Flagship portfolio, as chairman of its board.

He brings over 25 years of drug development, commercialisation and leadership experience within the pharmaceuticals industry, most recently as chief executive officer of Novartis Pharmaceuticals.

Prior to taking up this lead role in 2010, Epstein founded Novartis Oncology and Novartis Molecular Diagnostics in 1989, leading the start-up businesses as president and chief executive officer.

Dr Noubar Afeyan, founder and chief executive of Flagship, said: “David is a leader and long-time pioneer within the pharma industry, having developed dozens of new medicines benefiting millions of patients around the world.

“His progressive approach to science and business acumen gleaned over his tenured career in the pharmaceutical industry complements Flagship's culture and team.

“We will apply his expertise broadly as we continue making and realising the maximum potential of disruptive innovations that yield unprecedented therapies.”

25th January 2017

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics